Pulse 탐색 nav.journalClub 토론 트렌드 연구자

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

April 4, 2026Open Access

Comparative Clinical Analysis of DPP-4 and SGLT2 Inhibitors: A Real-World Switch Study

Key Points

This research aims to compare the effects of switching to DPP-4 and SGLT2 inhibitors on metabolic markers in patients.
Conducted a clinical analysis of real-world data regarding medication switching.
Evaluated HbA1c levels after transitioning to DPP-4 inhibitors.
Assessed fasting plasma glucose (FPG) and liver-related metabolic parameters after switching to SGLT2 inhibitors.
Switching to DPP-4 inhibitors led to a significant reduction in HbA1c levels.
Transitioning to SGLT2 inhibitors improved fasting plasma glucose and liver-related metabolic parameters.

Abstract

Transitioning to DPP-4 inhibitors reduced HbA1c levels significantly, whereas switching to SGLT2 inhibitors improved FPG and liver-related metabolic parameters.

AI에게 질문

Like

Bookmark

Share

View Full Paper

AI에게 질문

Like

Bookmark

Share

View Full Paper

Cite This Study

Choe et al. (Thu,) studied this question.

synapsesocial.com/papers/69d0adc2659487ece0fa449a https://doi.org/https://doi.org/10.7570/jomes25049

Comparative Clinical Analysis of DPP-4 and SGLT2 Inhibitors: A Real-World Switch Study | Synapse